MISSISSAUGA, Ontario, Jan. 30, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced the executive management will participate in the 2018 BIO CEO and Investor Conference to be held February 12-13, 2018 in New York. Adrian Adams, Chief Executive Officer, will provide an overview of the Company at 11:00 a.m. local time on Tuesday, February 13, 2018.

A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at www.aralez.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular and other specialty areas. Aralez's Global Headquarters is in Ontario, Canada, the U.S. Headquarters is in Princeton, New Jersey and the Irish Headquarters is in Dublin, Ireland. More information about Aralez can be found at www.aralez.com.

Contact Information:
Aralez Pharmaceuticals US Inc.
Nichol Ochsner
Executive Director, 
Investor Relations & Corporate Communications
732.754.2545
nochsner@aralez.com

 

(PRNewsfoto/Aralez Pharmaceuticals Inc.)

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/aralez-to-present-at-the-2018-bio-ceo-and-investor-conference-300589826.html

SOURCE Aralez Pharmaceuticals Inc.